Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DoctorAdam vs Kin Meds

DoctorAdam
Graded #55

Higher grade

vs+2.799999999999997
Kin Meds
Graded #75

Lower grade

The verdict

DoctorAdam takes it — 75.7/100 to 72.9/100.

DoctorAdam grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DoctorAdam is a Shopify-based telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral tablet forms, with flat all-in monthly pricing covering physician evaluation,…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDoctorAdam +3
77
74
Dose & formulationKin Meds +5
88
93
Clinical oversightDoctorAdam +11
85
74
Labs & monitoringEven
53
53
FulfillmentDoctorAdam +7
79
72
Contract termsEven
55
55
DoctorAdam · left barKin Meds · right bar

The numbers

MetricDoctorAdamKin Meds
WeighScore75.7/10072.9/100
GradeCC
Scorecard rank#55#75
Semaglutide$129/mo (starting dose, compounded)$149/mo (brand Wegovy)
Tirzepatide$229/mo (starting dose, compounded)$149/mo (brand Zepbound)
Coverage44 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
DoctorAdam

Graded #55 · C

Strengths

  • Offers both injection and oral tablet forms of compounded semaglutide and tirzepatide
  • Flat all-in pricing — physician evaluation, medication, and free shipping included
  • Named pharmacy partners: Olympia Pharmaceuticals (Orlando, FL) and Carie Boyd Pharmaceuticals (Irving, TX)
  • LegitScript certified with 4.8/5 Trustpilot score from 5,400+ reviews and 100K+ patients
  • No hidden fees, no required recurring commitment, full refund if not prescribed

Where it loses points

  • Compounded medications are not FDA-approved individual drugs
  • No labs or dedicated coaching disclosed on public pages
  • Only 44 states served — AK, MA, MS, NJ, RI, and VT excluded despite homepage '50 states' claim
  • Dose-tier pricing not published; only starting prices visible without quiz
  • Shopify-based store rather than a dedicated health platform
Kin Meds

Graded #75 · C

Strengths

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where it loses points

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard